Key words: rat monoclonal antibody/medial iliac lymph node cells/rat-mouse hybridomas/cell fusion ABSTRACT.A novel method of preparing hybridomas producing rat monoclonal antibodies was established. The enlarged medial iliac lymph nodes from rats injected via hind footpads with an emulsion of antigen and Freund's adjuvant were used for cell fusion. Ovalbuminwas used as a representative antigen. The incidence of hybridomas producing antibody of interest with this method was about 10 times higher than that of hybridomas with the conventional method using mouse or rat spleen cells. The average percentages of hybridomas producing IgGl, IgG2a, IgG2b and IgG2c were 37.1%, 47.0%, 15.9% and 0.0%, respectively. A single injection with antigen was sufficient for immunization in this method.
In 1975, Kohler and Milstein first reported the cell fusion technique that made it possible to generate hybrid cell lines producing monoclonal antibodies (7). Since then, monoclonal antibodies have been used increasingly so as to be applied in almost all areas of life science. Reagents and myelomas for cell fusion have been improved (2, 3, 4, 5, 16) , and hybridoma technology is now firmly established. It is still difficult, however, to obtain desired monoclonal antibodies because of low incidence of positive hybridomas (i.e., hybridomas producing antibody of interest) when spleen cells are used as a source of B cells. In the past, we have established several experimental models of anti-glomerular basement membrane antibody-induced glomerulonephritis in rats (ll, 12, 13, 14) . Wefound in the early stage of our research that footpad injection as well as intraperitoneal injection of the nephritogenic antigen could induce severe nephritis in rats and that the rats showed hypertrophic medial iliac lymph nodes. We speculated that the medial iliac lymph nodes could be applied as a reliable source of B cells for producing hybridomas yielding monoclonal antibodies.
In this paper, we propose a novel method of producing monoclonal antibody comparing it with conventional methods. Our method is termed the rat lymph node method which consists of hind footpad injection of rat * To whomcorrespondence should be addressed. Abbreviations: BSA, bovine serum albumin; ELISA, enzymelinked immunosorbent assay; GBM, glomerular basement membrane.
and subsequent cell fusion with the enlarged lymph nodes. The conventional methods are termed mouse and rat spleen methods which consist of intraperitoneal immunization of an animal and subsequent cell fusion with the spleen. Ovalbuminwas used as a representative antigen.
The first half of this paper deals with comparison of the novel method and conventional methods. Wefound that the rat lymph node method was about 10 times moreeffective as the mouseand rat spleen methods.
The latter half of this paper describes factors that may affect the incidence of positive hybridomas in the rat lymph node method. The effect of booster injection, the timing of the cell fusion, and the use of the inguinal lymph nodes as a fusion partner were examined. We conclusively found that the booster injection was not necessary, that the timing of fusion was effective 2 weeks or later after the injection although the rate of positive wells decreased as time passed, and that the medial iliac lymph nodes were more suitable for the fusion than the inguinal lymph nodes.
MATERIALS AND METHODS
Immunization of animals. Mouse and rat spleen methods : Eight-week-old female BALB/c mice and WKY/NCrjrats (Charles River Japan, Inc., Yokohama) were injected intraperitoneally with an emulsion (0. ). HAT selection medium (100 /^I/well) was added to each well 4 days after the fusion. Culture medium was changed with fresh HATselection medium 8 days after the fusion. At day 1 1, supernatants were collected and screened. Screening assay. The supernatants were screened for production of anti-ovalbumin antibodies by solid-phase enzymelinked immunosorbent assay (ELISA). ELISA plates (Nunc, Roskilde, Denmark) were coated with ovalbumin (3 jug/ml; in phosphate-buffered saline) for 2 h at 37°C. The plates were washed and blocked with \% bovine serum albumin (BSA) for 1 h at 37°C. The plates were washed and the supernatant was added to each well. After 1 h incubation at 37°C, the plates were washed and peroxidase-conjugated rabbit antibody to rat immunoglobulins (Dako A/S) was added to each well (1:1000 dilution). After 1 h incubation at 37°C, the plates were washed and o-phenylenediamine (Wako Pure Chemical Industries, Osaka, Japan) was added to each well and incubated for 1 h at room temperature. The colorimetric reaction was stopped with 3 MH2SO4.Color changes were measured by a Bio-Rad model 450 microplate reader at 492 nm. Positive wells were defined as wells that showed 0.2 or more higher absorbance unit than the maximum value of the modewhenthe wells were classified in 20 ranks produced by difference of 0. 1 absorbance unit. Screening oflgG subclasses. IgG subclass of antibodies in the rat lymph node method was determined by ELISA. Peroxidase-conjugated sheep antibodies to rat IgGl, IgG2a, IgG2b
and IgG2c (The Binding Site, Birmingham, England) were used as secondary antibodies (1 : 1000 dilution). Effect of booster injection given 3 or 4 days before cell fusion. Eight-week-old female WKY/NCrjrats were injected with an emulsion (0.2 ml) containing 50 fig ovalbumin and Freund's complete adjuvant into the hind footpads. Cell fusion was performed without booster injection 4 weeks plus 3 or 4 days after the injection. Timing ofcellfusion in lymph node method. Rats were injected with the antigen emulsion as described above. The medial iliac lymph nodes were taken out from 3 rats per week 2, 3, 4, 5 and 7 weeks after the initial injection and the inguinal lymph nodes were taken out from the same rats 3 and 4 weeks after immunization. Cell fusion was performed with pooled cells (1 x 108) and the screening assay was performed as described above.
RESULTS
Rat medial iliac lymph nodes. The hind footpad injection of an emulsion containing antigen and adjuvant induced hypertrophy of the popliteal, inguinal and Serum titer was defined as the reciprocal of the highest dilution giving the value which was 0.1 absorbance unit higher than the control value by ELISA.
medial iliac lymph nodes in rats. The medial iliac lymph nodes were about 20 times as heavy as normal ones and contained about 1 x 108 cells 3 weeks after the injection (Fig.  1) .
Serum antibody titers. To confirm that the animals were immunizedsufficiently, the titer of serum antibody was measured on days ll, 21, 28 and 35 from the initial immunization (Table I ). The titers increased sufficiently in both mice and rats 4 weeks after the initial immunization. Titers of the sera from rats immunized via hind footpads were slightly higher than those of the sera from rats immunized intraperitoneally. Frequency offusion. Fig. 2 shows histograms of primary screening of the spleen methods and of the lymph node method. These were the results of 1 of 3 independent experiments. In the spleen methods, absorbance of negative wells, i.e., background values of absorbance were in the range of 0 to 0.1. In the lymph node method, absorbance of negative wells was in the range of 0.3 to 0.5 and was higher than that of the rat spleen method. This suggests that the medial iliac lymph nodes had more B cells producing ovalbumin-specific antibody than the spleen, although many B cells were not fused with myeloma cells. When the definition of positive wells is applied, 10 out of 384 wells were positive in both mouse and rat spleen methods and 90 wells in the rat lymph node method. Wells having absorbance over 1.0 were 8 in the mouse spleen method, 1 in the rat spleen method and 60 in the rat lymph node method. Table II shows the rate of positive wells in the 3 independent experiments. The average rate was about 2 to 3% in the spleen methods, whereas in the lymph node method the average rate was about 20%. Administration of antigen via hind footpads with subsequent fusion with medial iliac lymph node induced about 10 times higher incidence of positive hybridomas than that of the spleen method. IgG subclasses. IgG subclass of antibodies resulting from rat lymph node cell fusion was determined (Table  III) . On average 47.0% of positive hybridomas for ovalbumin produced IgG2a and 37.1% of IgGl and 15.9% of IgG2b. There were no IgG2c-producing hybridomas Fig. 2 . Histogram of screening of primary hybridoma supernatants by ELISA ll days after cell fusion. A, mouse spleen method; B, rat spleen method; C, rat lymph node method Table II . The rate of positive wells in the 3 different methods.
The number of positive wells/the number of total wells.
atall.
Effect of booster injection. The final booster is effective when it is given 3 or 4 days before fusion (10, 17). To examinethe effect of the booster injection in the lymph node method, medial iliac lymph node cells were fused with myeloma cells without a booster injection 4 weeks plus 3 or 4 days after the immunization. The rates of positive wells were 25 and 30% (99 and 115/384 wells). This result indicates that it is not necessary to
give the booster injection before fusion in the lymph node method.
Timingoffusion. The rate of positive wells was examined 2, 3, 4, 5 and 7 weeks after the initial immunization. As shown in Fig. 3 , the rate of positive wells was maximumat week 2 and decreased as time passed. The rates even at weeks 5 and 7 were higher than those of the conventional mousespleen methodat week 4. Inguinal lymph node fusions. Popliteal and inguinal lymph nodes also hypertrophied as did medial iliac lymph nodes whenantigens were administered via hind footpads. The popliteal lymph nodes contained a large amount of adjuvant oil, which made it difficult to precipitate the lymphocytes by centrifugation at 1,000
rpm. Therefore the popliteal lymph nodes were found to be unsuitable for cell fusion. Inguinal lymph nodes were tested and the rate of positive wells was 13.5% at 3 weeks and 3.1% at 4 weeks (Fig. 3) . These values were much lower than those of the medial iliac lymph nodes. Because the frequency of positive wells in the rat lymph node method was about 10 times higher than that in the spleen methods, better hybridomas can be selected from a large population of positive wells. Criteria for the selection are viability of hybridomas and the nature of antibodies, such as specificity, cross-reactivity, affinity, ability in immunostaining, and biological activity. Subclass difference is also important for the study using double immunostaining, and the three different IgG subclasses obtained by the lymph node method are Another advantage of the lymph node method is that a single injection of antigen emulsion is sufficient for immunization. This advantage saves not only time and effort but also amounts of immunogenswhich are often very valuable or difficult to obtain. Cell fusion would certainly be possible at any time 2 weeks after the injection.
Mouse SP2/O myelomacells were used as a fusion partner in the present study, but there was absolutely no trouble encountered at all. The rat x mouse hybridomas proliferated as well as mouse x mouse hybridomas did. One practical disadvantage of the rat x mouse hybridomas might be mandatoryuse of nude mice or nude rats for obtaining ascites. Because reliable rat myelomacells have already been established (4), if those cells are used as a fusion partner, there might be no disadvantage compared to the mouse conventional method. Mirza et al. reported that administration of antigen via mouse footpads with subsequent fusion of popliteal and inguinal lymph node lymphocytes induces a higher frequency of hybridomas secreting specific antibody than either intradermal immunization and lymph node lymphocyte fusion or conventional subcutaneous immunization and intraperitoneal boost followed by splenic lymphocyte fusion (8). The main differences between the method of Mirza et al. and the rat lymph node method are the animals used and the lymph nodes used. Rat footpad is naturally larger than that of mouse and is large enough to accept at least 0.2 ml of antigen emulsion. Whena rat was injected with 0.1 ml antigen emulsion, a small amount of injected antigen still remained in spots in the footpad 4 weeks after the injection. This indicated that draining lymph nodes had been exposed to antigens for a long time. It was also found in the present study that inguinal lymph nodes were less suitable for cell fusion because of their lower rates of positive hybridomas. The use of medial iliac lymph nodes from a single rat is enough for a single fusion, therefore the use of inguinal lymph nodes is not recommended. A certain stage of B cells is thought to be suitable for cell fusion to produce hybridomas which secrete antibodies (1, 6) . In the rat lymph node method, the rate of positive wells was the highest at 2 weeks aftet the injection and it decreased as time passed. Because the size of the medial iliac lymph nodes was almost the same in 2 to 7 weeks after the injection, and because the number of clonies per well was almost the same from fusion to fusion, the decrease of the rate of positive wells may be explained by the shifting of the stage of B cells into unsuitable stage. Ovalbumin is a protein from chicken eggs that has a molecular weight of 42,699 daltons (9). It is antigenic to rats and is often used as a carrier protein for producing antibodies to haptens. To demonstrate reliability of the lymph node method to other types of antigens, the following successful results are discussed below. Wehave recently produced a monoclonal antibody to type IV collagen a5 chain by using a 13-amino-acid-residue synthetic peptide as antigen in the form conjugated to keyhole limpet hemocyanin (18). In general, the probability that monoclonal antibody produced to a synthetic peptide reacts with a native antigen is low. Usually, repeated cell fusions are required to obtain the desired monoclonal antibody. When we applied our novel lymph node method to type IV collagen a5 chain, 34 wells were positive to the synthetic peptide by ELISA, but only 3 of them were positive to the native antigen. One of the 3 wells was used for subcloning and a clone was established. The antibody produced by the clone could be used in western blotting and in staining of tissue sections. The use of the rat lymph node method is strongly recommended for this kind of work using synthetic peptides as antigens.
While studying anti-glomerular basement membrane (GBM)nephritis, which is an autoimmune disease induced by autoantibodies against type IV collagen in glomerular basement membrane,we were able to establish 2 hybridoma clones which produced nephritogenic autoantibodies belonging to IgG2a (14) . These clones were obtained from 3 separate fusions by rat spleen method. We have since applied the rat lymph node method to obtain other types of nephritogenic antibodies of different IgG subclasses. Wewere able to obtain 122 positive wells against rat GBMin indirect immunofluorescence. Weestablished 2 clones of hybridomasproducing IgGl and 2 clones producing IgG2b from the positive wells (15) . Antibodies from these clones were definitely nephritogenic although the severity of nephritis varied from antibody to antibody. They were autoantibodies with biological activities. We therefore believe that our novel method using rat medial iliac lymph node is certainly reliable and applicable for production of new monoclonal antibodies. Haring, P. 1980 {Received for publication, January 12, 1995 and in revised form, February 17, 1995) 
